机构

• 上海药物研究所 [11]

采集方式

• OAI收割 [11]

内容类型

• 期刊论文 [11]

发表日期

• 2018 [1]
• 2017 [2]
• 2016 [2]
• 2015 [2]
• 2014 [2]
• 2013 [1]
• 更多

学科主题

筛选

浏览/检索结果: 共11条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序发表日期升序发表日期降序题名升序题名降序作者升序作者降序 Improved Protein Toxin Delivery Based on ATTEMPTS Systems 期刊论文  OAI收割 CURRENT DRUG TARGETS, 2018, 卷号: 19, 期号: 4, 页码: 380-392 作者:  Chen, Yingzhi;  Zhang, Meng;  Min, Kyoung Ah;  Wang, Huiyuan;  Shin, Meong Cheol   |  收藏  |  浏览/下载：20/0  |  提交时间：2019/01/08 Protein toxin  ribosome-inactivating protein  immunotoxin  cell-penetrating peptide (CPP)  gelonin  tumor-targeting delivery   Tandem-multimeric F3-gelonin fusion toxins for enhanced anti-cancer activity for prostate cancer treatment 期刊论文  OAI收割 INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2017, 卷号: 524, 期号: 1-2, 页码: 101-110 作者:  Shin, Meong Cheol;  Min, Kyoung Ah;  Cheong, Heesun;  Moon, Cheol;  Huang, Yongzhuo   |  收藏  |  浏览/下载：27/0  |  提交时间：2019/01/08 Gelonin  Ribosome inactivating protein  F3 peptide  Prostate cancer  Multimeric   Heparin-Regulated Prodrug-Type Macromolecular Theranostic Systems for Cancer Therapy 期刊论文  OAI收割 Nanotheranostics, 2017, 卷号: 1, 期号: 1, 页码: 114-130 作者:  Wang, Huiyuan;  Moon, Cheol;  Shin, Meong Cheol;  Wang, Yaping;  He, Huining   |  收藏  |  浏览/下载：11/0  |  提交时间：2019/01/08 Preparation and Characterization of Gelonin-Melittin Fusion Biotoxin for Synergistically Enhanced Anti-Tumor Activity 期刊论文  OAI收割 PHARMACEUTICAL RESEARCH, 2016, 卷号: 33, 期号: 9, 页码: 2218-2228 作者:  Shin, Meong Cheol;  Min, Kyoung Ah;  Cheong, Heesun;  Moon, Cheol;  Huang, Yongzhuo   |  收藏  |  浏览/下载：17/0  |  提交时间：2019/01/08 cancer  gelonin  melittin  ribosome inactivating protein  toxin   Nose-to-brain delivery of macromolecules mediated by cell-penetrating peptides 期刊论文  OAI收割 ACTA PHARMACEUTICA SINICA B, 2016, 卷号: 6, 期号: 4, 页码: 352-358 作者:  Lin, Tingting;  Liu, Ergang;  He, Huining;  Shin, Meong Cheol;  Moon, Cheol   |  收藏  |  浏览/下载：26/0  |  提交时间：2019/01/08 Intranasal protein delivery  Brain targeting  Cell-penetrating peptide  Low molecular weigh protamine  Blood brain barrier   PTD-Modified ATTEMPTS for Enhanced Toxin-based Cancer Therapy: An In Vivo Proof-of-Concept Study 期刊论文  OAI收割 PHARMACEUTICAL RESEARCH, 2015, 卷号: 32, 期号: 8, 页码: 2690-2703 作者:  Shin, Meong Cheol;  Zhang, Jian;  Min, Kyoung Ah;  He, Huining;  David, Allan E.   |  收藏  |  浏览/下载：14/0  |  提交时间：2019/01/08 anti-CEA monoclonal antibody  cancer  heparin  protein transduction domains  toxin   Recombinant TAT-gelonin fusion toxin: Synthesis and characterization of heparin/protamine-regulated cell transduction 期刊论文  OAI收割 JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2015, 卷号: 103, 期号: 1, 页码: 409-419 作者:  Shin, Meong Cheol;  Zhao, Jingwen;  Zhang, Jian;  Huang, Yongzhuo   |  收藏  |  浏览/下载：18/0  |  提交时间：2019/01/08 gelonin  TAT  heparin  protamine  tumor   Low-molecular-weight protamine-modified PLGA nanoparticles for overcoming drug-resistant breast cancer 期刊论文  OAI收割 JOURNAL OF CONTROLLED RELEASE, 2014, 卷号: 192, 页码: 47-56 作者:  Wang, Huixin;  Zhao, Yongxing;  Wang, Huiyuan;  Gong, Junbo;  He, Huining   |  收藏  |  浏览/下载：13/0  |  提交时间：2019/01/08 Cell-penetrating peptide  PLGA nanoparticle  Doxorubicin  Low-molecular-weight protamine  Multidrug resistance  Breast cancer   CPP-mediated Protein Delivery in a Noncovalent Form: Proof-of-Concept for Percutaneous and Intranasal Delivery 期刊论文  OAI收割 PROTEIN AND PEPTIDE LETTERS, 2014, 卷号: 21, 期号: 11, 页码: 1129-1136 作者:  Wang, Zhao;  Chen, Yingzhi;  Liu, Ergang;  Gong, Junbo;  Shin, Meong Cheol   |  收藏  |  浏览/下载：28/0  |  提交时间：2019/01/08 Cell-penetrating peptide  noncovalent  nose-to-brain delivery  percutaneous delivery  protein delivery  TAT   Curb challenges of the "Trojan Horse" approach: Smart strategies in achieving effective yet safe cell-penetrating peptide-based drug delivery 期刊论文  OAI收割 ADVANCED DRUG DELIVERY REVIEWS, 2013, 卷号: 65, 期号: 10, 页码: 1299-1315 作者:  Huang, Yongzhuo;  Jiang, Yifan;  Wang, Huiyuan;  Wang, Jianxin;  Shin, Meong Cheol   |  收藏  |  浏览/下载：18/0  |  提交时间：2019/01/08 Cell-penetrating peptide (CPP)  Drug delivery system  Prodrug  Targeted delivery  In vivo